13 local life sciences drugs and devices to watch in 2019

It's a new year, and local life sciences companies are readying a stream of new products. A dozen Massachusetts companies are currently conducting final clinical tests and assessing rounds of data for an array of new treatments that could be sent to the FDA for approval in the next year. Among them are Vertex's highly anticipated triple combination Cystic Fibrosis drug, Intarcia's bele aguered diabetes device and Biogen's Alzheimer's treatment. Some companies are staring down a risk-filled path…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news